Study links empathy, self-esteem, and autonomy with increased sexual enjoyment
2011-06-04
(Press-News.org) Sexual pleasure among young adults (ages 18-26) is linked to healthy psychological and social development, according to a new study by researchers at the Johns Hopkins Bloomberg School of Public Health. The study is the first to use a representative population sample of heterosexuals to find a relationship between key developmental assets and sexual pleasure. The findings are published in the June 2011 issue of The Journal of Adolescent Health.
The research study examined data from 3,237 respondents ages 18 to 26 from the National Longitudinal Study of Adolescent Health, Wave III: 2001-2002. "Sexual health is more than the absence of sexually-transmitted infection, unintended pregnancy, violence or other problems. It is the presence of sexual well-being," said Adena Galinsky, PhD, co-author of the study and a doctoral student with Bloomberg School's Center for Adolescent Health. Galinsky, currently a post-doctoral fellow at the University of Chicago, conducted the study along with Freya Sonenstein, PhD, professor and director of the Center for Adolescent Health.
The study looked at the association between three developmental assets—self esteem, autonomy and empathy—and three measures of sexual pleasure among young adult women and men in established opposite-sex relationships: Regularity of orgasm, enjoyment of receiving oral sex, and enjoyment of performing oral sex. The findings include:
Among the young women, measures of self-esteem, autonomy, and empathy are positively associated with the three types of sexual pleasure. "These three developmental assets may enable young women, as well as young men, to experience higher levels of sexual pleasure," said Galinsky.
Sexual enjoyment in the three areas is consistently associated only with empathy for the young men. "Our hypothesis is that empathetic individuals are more responsive to a partner's needs, and thus initiate a positive feedback cycle," said Galinsky.
Young men are more likely to report the highest level of all three types of sexual enjoyment. For example, nearly 9 out of 10 young men report having an orgasm most or all of the time they have sex with their partner, while less than half of young women experience orgasm that frequently when they have sex with their partner.
Galinsky further theorizes that because young women face more barriers to sexual expression as compared to men, the achievement of sexual enjoyment may do more to boost their self-esteem and sense of autonomy. "Alternatively, these developmental assets may be more important to young women's sexual pleasure since they help them break down impediments to sexual communication and exploration," she said.
Sonenstein added that "in order to develop prevention initiatives that reduce sexual risk-taking leading to sexually transmitted disease and unintended pregnancy, program developers need a better understanding of the dynamics of sexual pleasure. Studies such as this one address the current lack of information about this topic."
INFORMATION:
The full article, "The Association Between Developmental Assets and Sexual Enjoyment Among Emerging Adults in the United States," can be viewed at www.jahonline.org.
Funding for the research was provided by the National Institute of Mental Health.
END
ELSE PRESS RELEASES FROM THIS DATE:
2011-06-04
Scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have demonstrated why certain immune cells chronically exposed to HIV shut down, and how they can be reactivated.
Healthy B cells have a balanced mix of surface proteins that the immune system can use, like the gas pedal and brake of a car, either to activate the cell or to damp down its activity. However, in people with long-term HIV infection who have not begun antiretroviral therapy, their B cells—responsible for producing anti-HIV antibodies—display ...
2011-06-04
Los Angeles, Calif., June 2, 2011—Researchers in the Keck School of Medicine of the University of Southern California (USC), together with scientists in Beijing, China, have discovered a chromosomal mutation responsible for a very rare condition in which people grow excess hair all over their bodies. Investigators hope the finding ultimately will lead to new treatments for this and less severe forms of excessive hair growth as well as baldness.
The study, "X-linked congenital hypertrichosis syndrome is associated with interchromosomal insertions mediated by a human-specific ...
2011-06-04
CHICAGO — Customizing targeted therapies to each tumor's molecular characteristics, instead of a one-size-fits-all approach by tumor type, may be more effective for some types of cancer, according to research conducted by The University of Texas MD Anderson Cancer Center.
MD Anderson's Phase I findings were presented today on the opening press program of the 47th Annual Meeting of the American Society of Clinical Oncology. Apostolia-Maria Tsimberidou, M.D., Ph.D., associate professor in MD Anderson's Department of Investigational Cancer Therapeutics, and the study's principal ...
2011-06-04
AURORA, Colo. (June 3, 2011) – A drug that targets a specific type of lung cancer shows a dramatic response in more than half of the people who take it. The drug, called crizotinib, has been in clinical trials since 2006, and the results from the largest group of patients to take it within the first of these clinical trials are being presented at the annual meeting of the American Society of Clinical Oncology (ASCO).
The patients taking crizotinib have anaplastic lymphoma kinase (ALK) positive advanced non-small cell lung cancer (NSCLC) and the drug targets the gene ...
2011-06-04
(CHICAGO) – For patients with advanced melanoma, which is the most lethal type of skin cancer, the results of a large clinical trial show that a vaccine combined with the immune-boosting drug Interleukin-2 can improve response rate and progression-free survival.
The findings of the study were published in the June 2 issue of New England Journal of Medicine. This marks the first vaccine study in the disease and one of the first in all cancers to show clinical benefit in a randomized Phase III clinical trial.
"This is the first time that a vaccine has shown benefit ...
2011-06-04
CHICAGO --- When people finish treatment for cancer, they want to bounce back to their former vital selves as quickly as possible. But a new Northwestern Medicine study -- one of the largest survivor studies ever conducted – shows many survivors still suffer moderate to severe problems with pain, fatigue, sleep, memory and concentration three to five years after treatment has ended.
"We were surprised to see how prevalent these symptoms still are," said study co-investigator Lynne Wagner, an associate professor of medical social sciences at Northwestern University Feinberg ...
2011-06-04
The pristine state of unpolluted waterways may be their downfall, according to research results published in a paper this week in the journal Geophysical Research Letters.
A species of freshwater algae that lives in streams and rivers, called Didymo for Didymosphenia geminata, is able to colonize and dominate the bottoms of some of the world's cleanest waterways--precisely because they are so clear.
Didymo does so with a little help from its friends--in this case, bacteria--which allow it to make use of nutrients like phosphorus.
Blooms of Didymo, also known as "rock ...
2011-06-04
Malta - May 2011 - Celebrations are certainly underway in D. R.'s household today, because he has just won over $82,000 playing at Maple Online Casino. He won a few prizes while playing different games, which makes his winnings even more impressive.
D. R. won $61,522.00 while playing Hitman; $12,050.00 on Multi-Hand European Blackjack; and $9,350.00 while playing Classic Blackjack. Thus, all his winnings for the day equal $82,922.00.
Casino Manager, Charlotte Jackson, was available for comment. "Congratulations D. R. We are very proud of your accomplishments ...
2011-06-04
CHICAGO -- ASCO Abstract #10504. Contrary to what many oncologists had thought, a tumor suppressor protein known as PTEN does not reduce the effectiveness of the breast cancer drug Herceptin, according to a study by Mayo Clinic and North Central Cancer Research Group (NCCTG) investigators. The study, which looked at tumors from 1,802 patients enrolled in the NCCTG N9831 clinical trial, found that patients with HER2-positive breast cancer and had either a loss of PTEN functioning or normal PTEN activity did equally well when Herceptin was added to chemotherapy to prevent ...
2011-06-04
BOSTON--A duo of drugs, each targeting a prime survival strategy of tumors, can be safely administered and are potentially more effective than either drug alone for advanced, inoperable melanomas, according to a phase 1 clinical trial led by Dana-Farber Cancer Institute investigators.
The findings (abstract 8511), will be presented in an oral session at the annual meeting of the American Society of Clinical Oncology on Saturday, June 4, 3 p.m. CT, Arie Crown Theater, McCormick Place.
The drugs -- ipilimumab and bevacizumab -- are both monoclonal antibodies, intensified ...
LAST 30 PRESS RELEASES:
[Press-News.org] Study links empathy, self-esteem, and autonomy with increased sexual enjoyment